Pharmaceutical Promotion and First Amendment Rights
Letter to the Editor

Resident Fellow
Scott Gottlieb, M.D.
Dr. Gottlieb and Mr. Troy comment on the constitutionality of off-label pharmaceutical promotion in response to the Journal's April 17 article Pharmaceutical Promotion to Physicians and First Amendment Rights.

Kesselheim and Avorn (April 17 issue)[1] dramatically understate the robust, sound constitutional protection the U.S. Supreme Court affords truthful, nonmisleading commercial communication such as that embodied in reprints of scientific articles discussing off-label uses.[2][3][4] Their suggestion that physicians need protection from the very journal articles they receive through subscription or library services is utterly at odds with the Court's forceful rejection of government paternalism.

Appropriate off-label use that informs proper patient care is fostered by more, not less, communication of truthful, nonmisleading information. It is unclear how articles published in the Journal lose their educational benefit and public health value (never mind constitutional protection) when manufacturers buy them as reprints from the Journal and distribute them to information-seeking physicians.

Scott Gottlieb, M.D., is a resident fellow at AEI.

Notes

1. Kesselheim AS, Avorn J. Pharmaceutical promotion to physicians and First Amendment rights. N Engl J Med 2008;358:1727-1732.
2. Cincinnati v. Discovery Network, 507 U.S. 410 (1993).
3. Edenfield v. Fane, 507 U.S. 761 (1993).
4. Ibanez v. Florida Dept. of Business & Professional Regulation, 512 U.S. 136 (1994).

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Scott
Gottlieb

What's new on AEI

Obama should channel Reagan on Russia
image Tackling our nation’s budget problems, head on
image Missing the point on inversions and corporate taxes
image Venezuela betrayed — missed chance to expose regime
AEI on Facebook
Events Calendar
  • 28
    MON
  • 29
    TUE
  • 30
    WED
  • 31
    THU
  • 01
    FRI
Tuesday, July 29, 2014 | 10:00 a.m. – 12:00 p.m.
Is Medicare's future secure? The 2014 Trustees Report

Please join AEI as the chief actuary for Medicare summarizes the report’s results, followed by a panel discussion of what those spending trends are likely to mean for seniors, taxpayers, the health industry, and federal policy.

Friday, August 01, 2014 | 10:30 a.m. – 12:00 p.m.
Watergate revisited: The reforms and the reality, 40 years later

Please join us as four of Washington’s most distinguished political observers will revisit the Watergate hearings and discuss reforms that followed.

No events scheduled this day.
No events scheduled today.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.